Physician profile
Winston Ho
NPI 1194802454
$17,692.12
in general payments reported to CMS, 2019-2025
53 companies · $2,457 in 2025
The $2,457 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,069 · 2020: $2,000 · 2021: $3,374 · 2022: $3,183 · 2023: $2,178 · 2024: $2,431 · 2025: $2,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,066.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,942.30 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,805.59 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,427.41 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $1,241.16 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $1,179.60 | 2019-2025 | |
| Novo Nordisk INC | $1,118.46 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $780.01 | 2019-2025 | Jardiance, Synjardy |
| Merck Sharp & Dohme LLC | $760.59 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Astellas Pharma US INC | $635.57 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $627.96 | 2021-2025 | |
| Amgen INC. | $592.14 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbott Laboratories | $587.59 | 2021-2025 | Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $507.72 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $370.54 | 2019-2023 | Xarelto |
| Corcept Therapeutics | $340.62 | 2020-2025 | Korlym |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winston Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.